Hem › Typ 2-diabetes › Missouri › Kansas City
Kliniska studier för Typ 2-diabetes i Kansas City, MO
11 studier för Typ 2-diabetes söker deltagare vid platser i och runt Kansas City (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.
Officiell studietext (engelska)
Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
RekryterarFas 3
- Alliance for Multispecialty Research - Kansas City, Kansas City
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
RekryterarFas 3
- Johnson County ClinTrials, Kansas City
A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
RekryterarFas 3
- Research Site, Kansas City
A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
RekryterarFas 3
- Research Site, Kansas City
- Research Site, Kansas City
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
RekryterarFas 3
- Kansas City VA Medical Center, Kansas City
Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease
RekryterarFas 2
- Clinical Research Consultants, LLC, Kansas City
A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
RekryterarFas 3
- Research Site, Kansas City
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin
RekryterarFas 3
- Research Site, Kansas City
AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications
RekryterarFas 3
- Johnson County ClinTrials, Kansas City
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Alone or in Combination With Dapagliflozin Compared With Placebo in Adults With Type 2 Diabetes Mellitus
RekryterarFas 3
- Research Site, Kansas City
Study to Evaluate HM15275 in Subjects With Type 2 Diabetes Mellitus
RekryterarFas 2
- Clay Platte Family Medicine, Kansas City
Typ 2-diabetes-studier i andra städer
- San Antonio, TX37 studier
- Houston, TX31 studier
- Orlando, FL25 studier
- Boston, MA20 studier
- Chicago, IL19 studier
- Dallas, TX19 studier
- Miami, FL19 studier
- Columbus, OH18 studier
- Las Vegas, NV18 studier
- San Diego, CA17 studier
- Atlanta, GA17 studier
- Los Angeles, CA16 studier
Andra studier i Kansas City
- Bröstcancer34 studier
- Icke-småcellig lungcancer31 studier
- Hjärtsvikt25 studier
- Cancer (alla typer)21 studier
- Lungcancer19 studier
- Kolorektal cancer16 studier
- Metastaserande cancer15 studier
- Akut myeloid leukemi15 studier
- Prostatacancer14 studier
- Äggstockscancer11 studier
- Övervikt11 studier
- Hjärt-kärlsjukdom11 studier
Från ClinicalTrials.gov, data hämtad 6 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.